## STE: STERIS plc - XLV: Healthcare

### Executive Summary

No thesis match: MRS_20 -1.6% below STRENGTH zone (4.0-10.0%); PEG 1.75 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: declining volume (52% of avg).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($246.20)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 2, Bearish: 0)

**1. Earnings Tell The Story For STERIS plc (NYSE:STE)**
- Source: Simply Wall Street | 20251226T193127 | Somewhat-Bullish | Relevance: 100%
- STERIS plc (NYSE:STE) currently has a high price-to-earnings (P/E) ratio of 36.4x, which is significantly above the market average. This elevated P/E is justified by the company's strong recent earnings growth of 17% and projected future growth of 14% per year, outpacing the broader market's 11% forecast. Investors seem to expect continued strong performance from STERIS, supporting its premium valuation.

**2. Valley National Advisers Inc. Invests $2.04 Million in STERIS plc $STE**
- Source: MarketBeat | 20251228T130139 | Bullish | Relevance: 100%
- Valley National Advisers Inc. recently acquired a new stake of 8,265 shares in STERIS plc (NYSE:STE) during the third quarter, valued at approximately $2.04 million. This investment comes amidst significant institutional ownership of 94.69% and recent insider selling totaling $6.62 million. STERIS, a medical equipment provider, reported strong Q3 results, beating EPS and revenue estimates, and has a "Moderate Buy" consensus rating from analysts with an average price target of $273.50.

**3. Harbor Capital Advisors Inc. Has $633,000 Stock Position in STERIS plc $STE**
- Source: MarketBeat | 20251228T111054 | Somewhat-Bullish | Relevance: 100%
- Harbor Capital Advisors Inc. significantly reduced its stake in STERIS plc by 71.1% in Q3, now holding 2,559 shares valued at approximately $633,000. Despite recent insider selling totaling $6.62 million, STERIS recently surpassed quarterly EPS estimates and provided optimistic FY2026 guidance. The company, which pays a quarterly dividend of $0.63, has a market cap of $25.06 billion, a consensus analyst target of $273.50, and institutional ownership of 94.69%.

**4. Earnings Tell The Story For STERIS plc (NYSE:STE)**
- Source: Simply Wall Street | 20251226T190840 | Somewhat-Bullish | Relevance: 100%
- STERIS plc (NYSE:STE) currently exhibits a high P/E ratio of 36.4x, significantly above the U.S. market average, which could signal bearish sentiment. However, this elevated P/E is supported by the company's strong recent earnings growth of 17% and projected future EPS growth of 14% per year, surpassing the market forecast of 11%. This suggests investors anticipate continued robust performance.

**5. What Makes Steris (STE) a New Buy Stock**
- Source: Nasdaq | 20251226T170838 | Bullish | Relevance: 100%
- Steris (STE) has been upgraded to a Zacks Rank #2 (Buy) due to an upward trend in its earnings estimates. This upgrade indicates a positive outlook for the company's earnings, which often correlates with an increase in stock price. The Zacks rating system is based on earnings estimate revisions and is considered a powerful tool for individual investors to identify potential market-beating returns.

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 0 ($0.00M) |
| Sells | 11 ($0.79M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 46.4% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Vanguard Group Inc: 12.4% (+0.4%)
- Blackrock Inc.: 8.9% (+1.3%)
- Massachusetts Financ: 4.9% (-7.7%)
- State Street Corpora: 4.4% (+4.0%)
- Morgan Stanley: 4.3% (+8.3%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.75 elevated, pricing in significant growth expectations. Forward P/E 22.9x stretched relative to 9% growth. Balance sheet: strong liquidity (2.4x), low leverage (D/E 0.48). Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $25.2B |
| Beta | 1.01 |
| 52W Range | $200.98 - $268.60 |
| Short Interest | 1.6% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.75 |
| Forward P/E | 22.9 |
| Current P/E | 25.0 |
| YoY Growth | 9.1% |
| EPS Direction | STABLE |

### Technicals

MRS_20 improving modestly (+0.6% over 5 days). Below STRENGTH zone by 5.5pp (needs >4.0% for momentum thesis). Long-term uptrend intact (above SMA200 at 1.06x) but short-term weakness (below SMA20). RSI neutral at 49. Volume at 52% of 20MA suggests lack of conviction. OFD pattern: -DBL (Indecision).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -1.55% (CS: 31) | Neutral |
| RSI_14 | 49.4 | Neutral |
| MACD Histogram | -0.41 | Bearish |
| vs SMA20 | 0.994x | Below |
| vs SMA50 | 1.008x | Above |
| vs SMA200 | 1.065x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $255.38
- **Stop Loss:** $246.20 (3.6% risk)
- **Target:** $264.56 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 143
- **Position Value:** $36,519.34
- **Portfolio %:** 36.52%
- **Risk Dollars:** $1,320.00
- **Risk Per Trade:** 1.32%
- **Modifiers:** L1 110% | L2 120% | Combined 1.32x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.10x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with selective risk appetite amid holiday trading. VIX at extreme lows (13.6) signals complacency while positive yield curve (+59bps) and stable economic data support continuation. Focus on quality names with AI/infrastructure exposure while monitoring January volatility reset.*

### Earnings

**Next:** 2026-02-04 (Est: $2.53)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $2.35 | $2.47 | +5.1% |
| 2025Q2 | $2.26 | $2.34 | +3.4% |
| 2025Q1 | $2.60 | $2.74 | +5.4% |
| 2024Q4 | $2.32 | $2.32 | -0.1% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_20*